Dengvaxia controversy
id:
dengvaxia-controversy-177-12182776
title:
Dengvaxia controversy
text:
The Dengvaxia controversy occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. The program was stopped when Sanofi Pasteur advised the government that the vaccine could put previously uninfected people at a somewhat higher risk of a severe case of dengue fever through anti
brand slug:
wiki
category slug:
encyclopedia
description:
Dengue vaccine controversy
original url:
https://en.wikipedia.org/wiki/Dengvaxia_controversy
date created:
2017-12-04T05:51:45Z
date modified:
2024-09-04T02:06:08Z
main entity:
{"identifier":"Q48802585","url":"https://www.wikidata.org/entity/Q48802585"}
image:
fields total:
13
integrity:
15